MGI Tech Co., Ltd. (SHA:688114)
China · Delayed Price · Currency is CNY 52.66
+1.61 (3.15%)
At close: May 7, 2026
MGI Tech Revenue
MGI Tech had revenue of 585.34M CNY in the quarter ending March 31, 2026, with 28.63% growth. This brings the company's revenue in the last twelve months to 2.90B, down -1.86% year-over-year. In the year 2025, MGI Tech had annual revenue of 2.78B, down -7.73%.
Revenue (ttm)
2.90B
Revenue Growth
-1.86%
P/S Ratio
7.50
Revenue / Employee
1.11M
Employees
2,604
Market Cap
21.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.78B | -232.92M | -7.73% |
| Dec 31, 2024 | 3.01B | 101.31M | 3.48% |
| Dec 31, 2023 | 2.91B | -1.32B | -31.19% |
| Dec 31, 2022 | 4.23B | 302.16M | 7.69% |
| Dec 31, 2021 | 3.93B | 1.15B | 41.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Yuyue Medical Equipment & Supply | 7.89B |
| Lepu Medical Technology (Beijing) | 6.42B |
| Autobio Diagnostics | 4.22B |
| Shandong Weigao Blood Purification Products | 3.78B |
| Cofoe Medical Technology | 3.66B |
| APT Medical | 2.72B |
| Double Medical Technology | 2.69B |
| Jafron Biomedical | 2.02B |